Teva Confirms Efficacy and Safety of AJOVY® (fremanezum

AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month



All critical efficacy endpoints met significance as set out apriori through hierarchical...

Related Keywords

South Korea , Japan , Takeshima , Japan General , China , Chinese , Theo Vos , Eric Hughes , Tarun Dua , Bochen Cao , Chiara Servili , Christopherjl Murray , Emma Nichols , Katrin Seeher , Jaimied Steinmetz , Vanessa Cavallera , Shengyuan Yu , Valeryl Feigin , Teva Pharmaceutical Industries Ltd , Teva Pharmaceuticals , Department Of Neurology , Teva Pharmaceutical Industries , Executive Vice President , Chief Medical Officer , Pharmaceutical Industries , Private Securities Litigation Reform Act , Annual Report , Headache Pain , Chinese Journal , Pain Medicine Chinese Journal , Pain Medicine , Nicoline Schiess , Kanyin Liane Ong , Global Burden , Disease Study , Markets ,